Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Construction of helicates based on six-coordinated silicon centres

Yu-Tao Guana, Heng Jia, Ju Yanga, Sai-Sai Yua and Ming Liu*ab
aDepartment of Chemistry, Zhejiang University, Hangzhou, 310058, China
bHangzhou Global Scientific and Technological Innovation Center (HIC), Zhejiang University, Xiaoshan, Hangzhou 311215, China. E-mail: mingliu@zju.edu.cn

Received 6th May 2025 , Accepted 14th July 2025

First published on 16th July 2025


Abstract

A class of triple-stranded helicates based on six-coordinate silicon centres has been constructed through self-assembly of achiral catechol ligands, as confirmed by single-crystal X-ray diffraction. These architectures demonstrate stability across physiological environments at pH = 3–12. Ligand rigidity dictates chiral configurations: rigid scaffolds form ΛΛ/ΔΔ racemic helicates, while flexible linkers enable dynamic equilibration with ΛΔ mesostates, observable by NMR. Host–guest interactions drive mesocate to helicate conversion, imparting cage-like guest recognition behavior. The helicates combine the biocompatibility of silicon with ligand-controlled chirality switching, offering potential for biomimetic applications.


Introduction

Supramolecular self-assembly, governed by non-covalent interactions, serves as the fundamental driving force for the formation of numerous ordered architectures in nature. Notably, naturally occurring helical motifs, such as the DNA double helix and the collagen triple helix, are ubiquitously distributed across biological systems and play pivotal roles in vital life processes.1 Inspired by these natural helices, which exhibit an exquisite integration of structural elegance and functional significance, extensive research efforts have been devoted to the rational design and synthesis of artificial helical architectures, particularly supramolecular helices with highly tunable properties, to develop biomimetic analogs with advanced functionalities. Conventionally, the construction of supramolecular chiral assemblies relies on chiral building blocks, whereas achieving well-defined chiral nanostructures from entirely achiral molecular motifs remains a significant challenge in the field.2

Metal–ligand self-assembly enables the construction of complex architectures from simple organic ligands. Through dynamic and pre-designed coordination interactions, a diverse array of supramolecular structures, including metal–organic cages (MOCs), coordination polymers (CPs), metal–organic frameworks (MOFs), molecular knots, etc., have been successfully assembled.3 Among these, one of the most fundamental motifs is the triple helix structure, which consists of two octahedral metal centres bridged by organic ligands.4 In 1987, Lehn et al. introduced the term “helicate” to describe such metal-coordinated self-assembled structures.5 In fact, helicates can essentially be viewed as simplified coordination cages. Nevertheless, such unique “coordination cages” seldom exhibit host–guest complexation capabilities due to their limited cavity size.6 Recent developments have successfully extended their construction to incorporate numerous metal ions including Ga3+, Fe2+, Ti4+, Zn2+, etc., for the formation of helical structures.7 Recently, Zhang et al. successfully constructed helical polymers ranging from self-organized to mechanically entangled architectures through supramolecular interactions between achiral tetracoordinate borate complexes.8 Despite these advances, metal-centered triple helicates often exhibit limited biocompatibility, which restricts their applicability in biological systems. To address this challenge, the development of helicates with biocompatible coordination centres—instead of heavy metals—represents a promising strategy for constructing highly biomimetic helical structures with enhanced biological relevance.

Silicate materials have garnered significant attention in tissue engineering and regenerative medicine due to their unique “bioactive-degradable-multifunctional” triad of properties.9 While silicon typically exists in four-coordinate configurations in silicate systems, recent work by Jiang et al. has expanded this paradigm by demonstrating that silicon can also adopt planar quadrilateral geometries in covalent organic frameworks (COFs) through strategic d-orbital hybridization.10e Nevertheless, the presence of accessible d-orbitals enables the formation of higher coordination states (five- or six-coordinate species), though such structures generally require stabilization by highly electronegative elements (F, O, and N), as exemplified by the classic SiF62−. The dynamic character of Si–O bonds has more recently facilitated their incorporation into COFs,10 coordination polymers11 and coordination organic cages.12 Despite these advances, the construction of triple-stranded helices centered on six-coordinate silicon remains unexplored.

Herein, we have developed a class of helical architectures based on six-coordinate silicon centres, with single-crystal XRD analysis unambiguously confirming the formation of these six-coordinate species, which exhibit acid–base stability in physiological environments (Scheme 1b). Systematic investigations reveal that structural control can be achieved through judicious ligand design: branched rigid ligands afford ΛΛ/ΔΔ racemic mixtures, ligands with defined dihedral angles yield an additional ΛΔ mesocate, and flexible ligands enable dynamic interconversion from ΛΛ/ΔΔ to ΛΔ states observable on the NMR timescale. The incorporation of suitable guest molecules induces conformational adaptation, driving the transformation from ΛΔ to ΛΛ/ΔΔ (Scheme 1a).


image file: d5sc03271g-s1.tif
Scheme 1 (a) Representative Si–O coordination modes used in the construction of supramolecular structures in previous studies. (b) Construction of chiral helices by achiral ligands based on six-coordinated [SiO6]2−. (c) Single-crystal structures of five helicates with different catechols (the distance between two [SiO6]2− centres in the single-crystal structure was measured).

Results and discussion

Catechol was chosen as an ideal ligand for reaction with Si(OMe)4 due to its distinctive diphenol chelate structure. For instance, the diamine ligand N,N′-([1,1′-biphenyl]-4,4′-diyl)bis(2,3-dihydroxybenza-mide) (H4B) was synthesized through amide condensation between p-phenylenediamine (NH2B) and 2,3-dimethoxybenzoyl chloride in DCM solvent with Et3N as the acid scavenger, yielding Me4B in 82%. Subsequent demethylation of Me4B using BBr3 produced H4B in 87% yield. All other catechol ligands were synthesized following identical reaction conditions (Fig. S1, ESI).

The reaction of H4B, MeONa, and Si(OMe)4 in a stoichiometric ratio of 3[thin space (1/6-em)]:[thin space (1/6-em)]4[thin space (1/6-em)]:[thin space (1/6-em)]2 in methanol at room temperature for 4 days yielded the triple-stranded helicate Na4[Si2B3] in 75.8% yield (Fig. 1a and b). Under identical conditions, Na4[Si2A3] was similarly obtained. As illustrated in Fig. 2a, the conversion of H4B to the helicate Na4[Si2B3] was accompanied by significant upfield shifts of the aromatic protons. Notably, the amide proton Hf exhibited a substantial downfield shift from 10.4 to 12.0 ppm, attributed to the formation of a stronger intramolecular hydrogen bond with the deprotonated phenolic hydroxyl group. Diffusion-ordered 1H NMR spectroscopy (DOSY) experiments not only confirmed the presence of discrete species but also provided crucial diffusion coefficient data, serving as evidence for the subsequent formation of chiral isomers (Fig. 1c and Table 1). The 29Si NMR spectrum displayed a characteristic singlet at −141.1 ppm (Fig. S18, ESI), a chemical shift significantly upfield compared to those of tetrahedral Si(OMe)4 (−35 to −50 ppm) and the planar quadrilateral SiO4 moieties in reported COFs (−100 ppm), further confirming the unique electronic environment of the six-coordinate silicon species.10e ESI-MS analysis of Na4[Si2B3] in methanol revealed charge-state distributions from 3 to 1 for the [2 + 3] helicate assembly (Fig. S35–S38, ESI), providing additional confirmation of the helical structure formation.


image file: d5sc03271g-f1.tif
Fig. 1 (a) Schematic diagram of synthesizing Na4[Si2L3] from H4L (L = A–E). (b) Comparison of 1H NMR spectra (600 MHz, DMSO-d6, and 298 K) of H4B and Na4[Si2B3]. (c and d) Diffusion-ordered 1H NMR spectroscopy (DOSY) spectra (500 MHz, DMSO-d6, and 298 K) of Na4[Si2B3] and Na4[Si2D3] (* represents helicates (ΛΛ/ΔΔ)).

image file: d5sc03271g-f2.tif
Fig. 2 1H NMR spectrum (600 MHz, DMSO-d6, 298 K) of the transformation of Na4[Si2D3] from helicates (ΛΛ/ΔΔ) to mesocate (ΛΔ) over time. (▲ represents helicates (ΛΛ/ΔΔ) and * represents mesocate (ΛΔ)).
Table 1 Hydrodynamic radii calculated from DOSY results
  lg[thin space (1/6-em)]D (lg cm2 s−1) D (10−7 cm2 s−1) ra (Å)
a The hydrodynamic radii (r) of the indicated helicates were calculated by using the Stokes–Einstein equation r = kT/6πηD, where k is the Boltzmann constant (1.3807 × 10−23 m2 kg s−2 K−1), T is the temperature in Kelvin, η is the viscosity of the solution (1.19 × 10−3 kg m−1 s−1 for DMSO), and D is the diffusion coefficient.
Na4[Si2A3] −6.055 8.810 12.41
Na4[Si2B3] −6.128 7.447 14.69
Na4[Si2C3] −6.130 7.413 14.76
Na4[Si2D3] −6.068 8.551 12.79
Na4[Si2E3] −6.067 8.570 12.77


In contrast to other derivatives, the reactions of Na4[Si2C3], Na4[Si2D3] and Na4[Si2E3] required 80 °C to proceed efficiently, likely due to the presence of ligand dihedral angles that facilitate oligomer formation, and therefore elevated reaction temperatures are needed to accelerate the Si–O dynamic reversible process (Fig. S27, ESI). 1H NMR spectroscopy revealed distinct structural behaviors among the complexes. While Na4[Si2A3] and Na4[Si2B3] each displayed a single resonance signal, Na4[Si2C3] and Na4[Si2D3] exhibited two discrete signals (Fig. S7–S10, ESI). Notably, these signals gradually equilibrated to a fixed ratio over time, with this phenomenon being particularly pronounced in Na4[Si2D3]. In contrast, Na4[Si2C3] showed only minor spectral changes. DOSY spectroscopy confirmed that all species possessed identical diffusion coefficients, effectively excluding the possibility of higher-order assemblies with increased combinatorial complexity (Fig. 1d). The differences in spectra arise from the interplay between the helical chirality at the complexation centres of the helicates and the conformational flexibility of the linkages (H4C, H4D, and H4E). This combination enables dihedral angle modulation, resulting in the coexistence of helicate (ΛΛ/ΔΔ) and mesocate (ΛΔ) chiral isomers.

Single crystals suitable for X-ray diffraction were successfully obtained through vapor diffusion of diethyl ether into methanol solutions of the five helicates. X-ray crystallographic analysis revealed distinct configuration preferences among these complexes: the spiral chiral centres in Na4[Si2A3] and Na4[Si2B3] exclusively adopted the helicate (ΛΛ/ΔΔ) configuration, consistent with their observation of a single set of signals in the 1H NMR spectra. In contrast, Na4[Si2C3] and Na4[Si2D3] crystallized in the mesocate (ΛΔ) configuration, with no evidence of ΛΛ/ΔΔ conformers observed in the solid state (Fig. 3a). This configurational preference likely stems from the comparable thermodynamic stability of both helicate and mesocate forms, resulting in their coexistence during the synthetic process. Solution-phase studies revealed a gradual conversion from helicate to mesocate configurations over time, with the transformation kinetics being particularly accelerated in Na4[Si2D3]. The enhanced conformational flexibility imparted by the ether linkage in this complex facilitated rapid configurational interconversion, as evidenced by the evolution of the 1H NMR signals from an initial 53[thin space (1/6-em)]:[thin space (1/6-em)]47 (mesocate[thin space (1/6-em)]:[thin space (1/6-em)]helicates) ratio to a final equilibrium ratio of 88.5[thin space (1/6-em)]:[thin space (1/6-em)]11.5 (Fig. 2). These observations highlight the critical role of ligand flexibility in governing the dynamic equilibrium between different helical configurations. Furthermore, when acetonitrile is employed as the crystallization solvent, well-ordered layered structures will be obtained. In contrast, methanol exhibits strong solvation effects toward Na+, occupying its coordination sites and consequently leading to relatively disordered structures (Fig. 3c and d).


image file: d5sc03271g-f3.tif
Fig. 3 (a) Helical chiral configurations of five assemblies as illustrated in the single-crystal structures. (b) The cavity size of the Na4[Si2E3] ΛΛ/ΔΔ (for structural clarity and precision, the counterion Na+ and all hydrogens are omitted). (c and d) The SC-XRD diffraction packing pattern of Na4[Si2C3] single crystal obtained in acetonitrile/diethyl ether.

Previous research on Ti-centered helicates has demonstrated that ligands containing an odd number of connecting units preferentially form mesocates due to inherent geometrical constraints.13 Surprisingly, the Na4[Si2E3] exhibits an unusual helicate assembly behavior, contradicting conventional ligand structure-directing principles. Upon introduction of excess H2O and heating at 70 °C, we observe near-complete transformation from mesocate to helicate configurations (Fig. 4). Single-crystal X-ray analysis unambiguously confirms the encapsulation of Na(H2O)2+ units within the helicate cavity, providing direct evidence for host–guest complexation. Comparative structural analysis reveals that while the helicate's spacious cavity readily accommodates the Na(H2O)2+ guest (Fig. 3b), the more compact mesocate (exemplified by Na4[Si2C3] and Na4[Si2D3]) lacks the necessary space. A similar phenomenon has been observed by Raymond et al. in the conversion of thermodynamically stable mesocates into helicates upon interaction with suitable guest molecules.14 The guest-induced stabilization energy effectively offsets the helicate's intrinsic thermodynamic penalty, illustrating a remarkable example of supramolecular conformational adaptation through dynamic equilibrium control. This consequently endows the helicates with the host–guest recognition capability characteristic of the coordination cage.


image file: d5sc03271g-f4.tif
Fig. 4 Comparison of 1H NMR spectra (600 MHz, DMSO-d6, and 298 K) of mixtures of Na4[Si2E3] isomers before and after heating with excess H2O at 70 °C. (▲ represents helicates (ΛΛ/ΔΔ) and * represents mesocate (ΛΔ)).

The distinctive [SiO6]2− structure has prompted examination of its stability characteristics. This six-coordinate silicate structure, while theoretically expected to demonstrate significant pH sensitivity, exhibits remarkable stability when incorporated into the helicates based on six-coordinated silicon centres. Since all five helicates share identical [SiO6]2− fragments, we selected Na4[Si2B3] with its singular NMR signature as the representative system for investigation. The anionic nature of this compound enables aqueous solubility at physiological temperature (37 °C), with 1H NMR analysis confirming structural integrity after 24 hours in solution. This stability stands in stark contrast to [SiO6]2−-containing COFs,9a which undergo structural degradation upon suspending in water or under humid conditions. The exceptional stability of Na4[Si2B3] could be attributed to stabilizing triple hydrogen bonds between the catechol ligand's N–H and the [SiO6]2− segment. Remarkably, the strongly alkali conditions employed in Na4[Si2B3] synthesis presage its alkali stability, with the structure demonstrating complete integrity even at pH = 12. Further stability testing revealed that the helical architecture remains essentially unchanged after 24 hours of exposure to weakly acidic conditions (pH = 3–4). Structural decomposition to the free H4B ligand occurs only when the pH is reduced to 2 (Fig. 5). The demonstrated pH stability range (pH = 3–12) encompasses nearly all physiological environments within the human body, while enabling selective decomposition and sustained drug release under highly acidic conditions, such as those found in gastric compartments or acid-exposed lesions. Additionally, the other four helicates demonstrate the same excellent stability (Fig. S28). Such characteristics position these highly coordinated silicon-based helical structures as promising candidates for biomedical applications, such as in targeted drug delivery systems and biosensor development, where pH stability across physiological ranges represents a critical requirement.


image file: d5sc03271g-f5.tif
Fig. 5 1H NMR spectrum (600 MHz, DMSO-d6, and 298 K) of Na4[Si2B3] in aqueous solutions at pH = 2, 3, 4, 7, and 12, respectively.

Conclusions

In summary, we have developed a category of supramolecular helicates based on six-coordinate silicon centres, which exhibit acid–base stability in physiological environments. A well-defined three-stranded helicate system was established through the controlled self-assembly of rationally designed catechol-derived ligands with Si(OMe)4. Single-crystal X-ray diffraction analysis unambiguously confirms the formation of [SiO6]2− coordination cores and elucidates the critical structure-directing role of ligand design: rigid ligands exclusively yield ΛΛ/ΔΔ racemic helicates, while flexible ligands enable dynamic equilibration between helicate (ΛΛ/ΔΔ) and mesocate (ΛΔ) conformations, as directly monitored by NMR spectroscopy. Remarkably, we demonstrate that host–guest interactions can override thermodynamic preferences, as evidenced by the Na(H2O)2+ encapsulation-induced stabilization of otherwise disfavored helicate configurations. This study expands the repertoire of coordination centres available for supramolecular helicates while addressing the biocompatibility limitations of conventional metal-based systems. More importantly, this work establishes a ligand engineering approach for precise control over helical dynamics, opening new avenues for designing biomimetic architectures.

Data availability

The data supporting this article have been included as part of the ESI. Crystallographic data (for compounds Na4[Si2A3], Na4[Si2B3], Na4[Si2C3], Na4[Si2D3] and Na4[Si2E3]) have been deposited at the CCDC under CCDC number (2447708–2447714) and can be obtained from https://www.ccdc.cam.ac.uk/.

Author contributions

Yu-Tao Guan: project design, synthesis, characterization, data analysis, and article writing. Heng Ji: crystal structure analysis. Ju Yang: theoretical guidance. Sai-Sai Yu: diagram preparation. Ming Liu: project design, theoretical direction, funding acquisition, project administration, resources, supervision, and writing – review & editing.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

The authors gratefully acknowledge the National Natural Science Foundation of China (no. 22371252), the Zhejiang Provincial Natural Science Fund (LZ23B020005), and the Leading Innovation Team grant from the Department of Science and Technology of Zhejiang Province (2022R01005). The authors also thanks the Roentgen Laboratory for XRD testing and technical support.

Notes and references

  1. (a) P. Zhan, A. Peil, Q. Jiang, D. Wang, S. Mousavi, Q. Xiong, Q. Shen, Y. Shang, B. Ding, C. Lin, Y. Ke and N. Liu, Chem. Rev., 2023, 123, 3976–4050 CrossRef CAS PubMed; (b) L. N. Green, H. K. K. Subramanian, V. Mardanlou, J. Kim, R. F. Hariadi and E. Franco, Nat. Chem., 2019, 11, 510–520 CrossRef CAS PubMed; (c) I. C. Tanrikulu, A. Forticaux, S. Jin and R. T. Raines, Nat. Chem., 2016, 8, 1008–1014 CrossRef CAS PubMed.
  2. (a) X. Zha, G. Xu, N. A. Khan, Z. Yan, M. Zuo, Y. Xiong, Y. Liu, H. You, Y. Wu, K. Liu, M. Li and D. Wang, Angew. Chem., Int. Ed., 2024, 63, e202316385 CrossRef CAS PubMed; (b) Q. Song, J. Yang, K. Zheng, T. Zhang, C. Yuan, L.-M. Yuan and X. Hou, J. Am. Chem. Soc., 2024, 146, 7594–7604 CrossRef CAS PubMed; (c) J. Zhang, K. Wu, X. Gao, M. Zhang, X. Zhou, F. Bertram, C. Shen and Y. Zhou, Sci. Adv., 2024, 10, eado5948 CrossRef CAS PubMed; (d) D. Wu, K. Zhou, J. Tian, C. Liu, J. Tian, F. Jiang, D. Yuan, J. Zhang, Q. Chen and M. Hong, Angew. Chem., Int. Ed., 2021, 60, 3087–3094 CrossRef CAS PubMed; (e) Y. Li, C. Liu, X. Bai, F. Tian, G. Hu and J. Sun, Angew. Chem., Int. Ed., 2020, 59, 3486–3490 CrossRef CAS PubMed; (f) X. Lou, K. Zhang, Y. Bai, S. Zhang, Y. Li and Y. Yang, Angew. Chem., Int. Ed., 2025, 64, e202414611 CrossRef CAS PubMed.
  3. (a) H.-N. Zhang and G.-X. Jin, Angew. Chem., Int. Ed., 2023, 62, e202313605 CrossRef CAS PubMed; (b) Q. Zhou, X. Dong, G. Chi, X.-Y. Cao, N. Zhang, S. Wu, Y. Ma, Z.-H. Zhang and L. Zhang, J. Am. Chem. Soc., 2024, 146, 22405–22412 CrossRef CAS PubMed; (c) H. Xu, T. K. Ronson, A. W. Heard, P. C. P. Teeuwen, L. Schneider, P. Pracht, J. D. Thoburn, D. J. Wales and J. R. Nitschke, Nat. Chem., 2025, 17, 289–296 CrossRef CAS PubMed; (d) J. Ruan, Y.-L. Lu, P. Hu and C.-Y. Su, J. Am. Chem. Soc., 2025, 147, 10475–10484 CrossRef CAS PubMed; (e) S. Wu, X. Huang, S. Fu, Z. Li, S. Yin, W. Liao, M. Wang, Y. Lu, M. Bonn, Y. Sun, X. Feng and W. Xu, Angew. Chem., Int. Ed., 2025, 64, e202419865 CrossRef CAS; (f) Y. Yang, C. Zhang, C. Zhang, Y. Shi, J. Li, B. Johannessen, Y. Liang, S. Zhang, Q. Song, H. Zhang, J. Huang, J. Ke, L. Zhang, Q. Song, J. Zeng, Y. Zhang, Z. Geng, P.-S. Wang, Z. Wang, J. Zeng and F. Li, Nat. Commun., 2024, 15, 6316 CrossRef CAS PubMed; (g) Y.-X. Tan, J. Lin, Q.-H. Li, L. Li, R. A. Borse, W. Lu, Y. Wang and D. Yuan, Angew. Chem., Int. Ed., 2023, 62, e202302882 CrossRef CAS PubMed; (h) L. Shi, Z. Xiong, H. Wang, H. Cao and Z. Chen, Chem, 2024, 10, 2464–2472 CrossRef CAS.
  4. (a) J. Jiao, J. Dong, Y. Li and Y. Cui, Angew. Chem., Int. Ed., 2021, 60, 16568–16575 CrossRef CAS PubMed; (b) J. Zhu, X.-W. Sun, X. Yang, S.-N. Yu, L. Liang, Y.-Z. Chen, X. Zheng, M. Yu, L. Yan, J. Tang, W. Zhao, X.-J. Yang and B. Wu, Angew. Chem., Int. Ed., 2023, 62, e202314510 CrossRef CAS PubMed; (c) R. Chen, Q.-Q. Yan, S.-J. Hu, X.-Q. Guo, L.-X. Cai, D.-N. Yan, L.-P. Zhou and Q.-F. Sun, Org. Chem. Front., 2021, 8, 2576–2582 RSC.
  5. J. M. Lehn, A. Rigault, J. Siegel, J. Harrowfield, B. Chevrier and D. Moras, Proc. Natl. Acad. Sci. U. S. A., 1987, 84, 2565–2569 CrossRef CAS.
  6. (a) T. Haino, H. Shio, R. Takano and Y. Fukazawa, Chem. Commun., 2009, 18, 2481–2483 RSC; (b) Y. Yamasaki, H. Shio, T. Amimoto, R. Sekiya and T. Haino, Chem.–Eur. J., 2018, 24, 8558–8568 CrossRef CAS PubMed; (c) X.-S. Du, Y. Han and C.-F. Chen, Chem. Commun., 2022, 58, 1326–1329 RSC.
  7. (a) K. J. Howard-Smith, A. R. Craze, H. Zenno, J. Yagyu, S. Hayami and F. Li, Chem. Commun., 2020, 56, 8838–8841 RSC; (b) M. Meyer, B. Kersting, R. E. Powers and K. N. Raymond, Inorg. Chem., 1997, 36, 5179–5191 CrossRef CAS; (c) C. Mevissen, A. C. N. Kwamen, L. Himmel, X. Chen, M. Brückner, S. Huda, C. Göb, J. Jenniches, I. Oppel, J. S. Ward, K. Rissanen and M. Albrecht, Eur. J. Org Chem., 2020, 32, 5161–5172 CrossRef; (d) X. Chen, T. M. Gerger, C. Räuber, G. Raabe, C. Göb, I. M. Oppel and M. Albrecht, Angew. Chem., Int. Ed., 2018, 57, 11817–11820 CrossRef CAS PubMed.
  8. (a) L. J. Wayment, S. J. Teat, S. Huang, H. Chen and W. Zhang, Angew. Chem., Int. Ed., 2024, 63, e202403599 CrossRef CAS PubMed; (b) Y. Hu, N. Dunlap, H. Long, H. Chen, L. J. Wayment, M. Ortiz, Y. Jin, A. Nijamudheen, J. L. Mendoza-Cortes, S.-h. Lee and W. Zhang, CCS Chem., 2021, 3, 2762–2770 CrossRef CAS; (c) Y. Hu, S. J. Teat, W. Gong, Z. Zhou, Y. Jin, H. Chen, J. Wu, Y. Cui, T. Jiang, X. Cheng and W. Zhang, Nat. Chem., 2021, 13, 660–665 CrossRef CAS PubMed; (d) Y. Yu, S.-H. Shen, J.-B. Chen, Q.-R. Ding, H.-X. Zhang and J. Zhang, J. Am. Chem. Soc., 2025, 147, 20770–20777 CrossRef PubMed.
  9. (a) Y. Han, L. Du, J. Wu, H. Zhang, G. Yang, Y. Zheng and C. Wu, Mater. Today, 2025, 83, 64–84 CrossRef CAS; (b) Z. Zhang, C. Fan, Q. Xu, F. Guo, W. Li, Z. Zeng, Y. Xu, J. Yu, H. Ge, C. Yang and J. Chang, Adv. Sci., 2024, 11, 2407718 CrossRef PubMed; (c) W. Ma, Y. Zheng, G. Yang, H. Zhang, M. Lu, H. Ma, C. Wu and H. Lu, Mater. Horiz., 2024, 11, 2957–2973 RSC; (d) P. Sun, Z. Zhang, F. Gao, C. Yang, G. Mang, S. Fu, J. Tian and J. Chang, Sci. Adv., 2025, 11, eadr7208 CrossRef CAS PubMed.
  10. (a) J. Roeser, D. Prill, M. J. Bojdys, P. Fayon, A. Trewin, A. N. Fitch, M. U. Schmidt and A. Thomas, Nat. Chem., 2017, 9, 977–982 CrossRef CAS PubMed; (b) O. Yahiaoui, A. N. Fitch, F. Hoffmann, M. Fröba, A. Thomas and J. Roeser, J. Am. Chem. Soc., 2018, 140, 5330–5333 CrossRef CAS PubMed; (c) X. Li, Y. Tian, L. Shen, Z. Qu, T. Ma, F. Sun, X. Liu, C. Zhang, J. Shen, X. Li, L. Gao, S. Xiao, T. Liu, Y. Liu and Y. Lu, Adv. Funct. Mater., 2021, 31, 2009718 CrossRef CAS; (d) C. Li, D.-D. Wang, G. S. H. P. Ho, Z. Zhang, J. Huang, K.-T. Bang, C. Y. Lau, S.-Y. Leu, Y. Wang and Y. Kim, J. Am. Chem. Soc., 2023, 145, 24603–24614 CAS; (e) Z. Liu, W. Liu, Y. Chen, X. Yang, Y. Liu, Y. Jin, Q. Xu, D. Qi, K. Wang, Y. Zhu and J. Jiang, CCS Chem., 2025, 7, 1812–1822 CrossRef.
  11. (a) M. Naoe, H. Iwashita, S. Saito, M. Koike, H. Wada, A. Shimojima and K. Kuroda, Chem. Lett., 2020, 49, 1075–1077 CrossRef CAS; (b) R.-L. Chai, X.-K. Zhang, Z. Zhao, T.-T. Li, G.-Y. Li, J. Zhao, G. Li, B. Cheng, Q. Zhao and S.-H. Li, ACS Mater. Lett., 2023, 5, 1376–1383 CrossRef CAS.
  12. (a) J. L. Holmes, B. F. Abrahams, A. Ahveninen, B. A. Boughton, T. A. Hudson, R. Robson and D. Thinagaran, Chem. Commun., 2018, 54, 11877–11880 RSC; (b) Y. Kawakami, T. Ogishima, T. Kawara, S. Yamauchi, K. Okamoto, S. Nikaido, D. Souma, R.-H. Jin and Y. Kabe, Chem. Commun., 2019, 55, 6066–6069 RSC; (c) C. M. Hong, M. Morimoto, E. A. Kapustin, N. Alzakhem, R. G. Bergman, K. N. Raymond and F. D. Toste, J. Am. Chem. Soc., 2018, 140, 6591–6595 CrossRef CAS PubMed; (d) K. T. Xia, A. Rajan, Y. Surendranath, R. G. Bergman, K. N. Raymond and F. D. Toste, J. Am. Chem. Soc., 2023, 145, 25463–25470 CrossRef CAS PubMed.
  13. M. Albrecht and S. Kotila, Angew. Chem., Int. Ed., 1995, 34, 2134–2137 CrossRef CAS.
  14. J. Xu, T. N. Parac and K. N. Raymond, Angew. Chem., Int. Ed., 1999, 38, 2878–2882 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available. CCDC 2447708–2447714. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d5sc03271g

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.